Evidence map›Paper›PMID 36011323›Full record

ArticleGenes2022

A Novel Intragenic Duplication in the

Cristina Lucia-Campos, Irene Valenzuela, Ana Latorre-Pellicer, David Ros-Pardo, Marta Gil-Salvador, María Arnedo, Beatriz Puisac, Neus Castells, Alberto Plaja, Anna Tenes and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Cristina Lucia-CamposUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.
Irene ValenzuelaDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Ana Latorre-PellicerUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.ORCID 0000-0002-4703-6620
David Ros-PardoCentro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Molecular Modeling Group, E-28049 Madrid, Spain.
Marta Gil-SalvadorUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.
María ArnedoUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.ORCID 0000-0001-9962-2157
Beatriz PuisacUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.
Neus CastellsDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Alberto PlajaDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Anna TenesDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Ivon CuscóDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Laura TrujillanoDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.ORCID 0000-0002-3028-6156
Feliciano J RamosUnit of Clinical Genetics, Department of Paediatrics, Service of Paediatrics, Hospital Clínico Universitario Lozano Blesa, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.ORCID 0000-0002-5732-2209
Eduardo F TizzanoDepartment of Clinical and Molecular Genetics Hospital Vall d'Hebron, E-08035 Barcelona, Spain.
Paulino Gómez-PuertasCentro de Biología Molecular Severo Ochoa, CBMSO (CSIC-UAM), Molecular Modeling Group, E-28049 Madrid, Spain.ORCID 0000-0003-3131-729X
Juan PiéUnit of Clinical Genetics and Functional Genomics, Department of Pharmacology-Physiology, School of Medicine, Universidad de Zaragoza, CIBERER-GCV02 and IIS-Aragon, E-50009 Zaragoza, Spain.ORCID 0000-0003-3203-6254
Universidad de Zaragoza · ESVall d'Hebron Institut de Recerca · ESCentro de Biología Molecular Severo Ochoa · ESHospital de Sant Pau · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cornelia de Lange syndrome (CdLS) is a multisystemic genetic disorder characterized by distinctive facial features, growth retardation, and intellectual disability, as well as various systemic conditions. It is caused by genetic variants in genes related to the cohesin complex. Single-nucleotide variations are the best-known genetic cause of CdLS; however, copy number variants (CNVs) clearly underlie a substantial proportion of cases of the syndrome. The

Indexed as

De Lange SyndromeCell Cycle ProteinsExonsHeterozygoteHistone DeacetylasesHumansPhenotypeRepressor ProteinsCell Cycle ProteinsHDAC8 protein, humanHistone DeacetylasesNIPBL protein, humanRepressor Proteinsarray CGHcopy number variantsCornelia de Lange syndromegenetic diagnosisgenetic disorderHDAC8intragenic duplication

Identifiers

PMID36011323
PMCPMC9408140
OpenAlexW4293514610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.